Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
BJU International|September 24, 2013
Population-based determinants of radical prostatectomy operative timeStacey C Carter, Stuart Lipsitz, Ya-Chen T Shih, et al.Pharmacoeconomics|March 15, 2011
Economic burden of renal cell carcinoma in the US: Part II--an updated analysisYa-Chen T Shih, Chun-Ru Chien, Ying Xu, et al.Expert Review of Pharmacoeconomics & Outcomes Research|April 11, 2013
Disparity implications of the Medicare medication therapy management eligibility criteria: a literature reviewKiraat D Munshi, Ya-Chen T Shih, Lawrence M Brown, et al.MDM Policy & Practice|February 20, 2020
Factors Associated With Hospital Decisions to Purchase Robotic Surgical SystemsChan Shen, Dian Gu, Roger Klein, et al.Cancer|February 21, 2008
In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies: clinical and economic outcomes from the Nationwide Inpatient SampleJeffrey A Jones, Muzaffar H Qazilbash, Ya-Chen T Shih, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 27, 2004
Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosisElenir B C Avritscher, Scott B Cantor, Ya-Chen T Shih, et al.The Journal of Supportive Oncology|January 27, 2011
Cost-utility analysis of palonosetron-based therapy in preventing emesis among breast cancer patientsElenir B C Avritscher, Ya-Chen T Shih, Charlotte C Sun, et al.Statistics in Medicine|August 22, 2023
A flexible quasi-likelihood model for microbiome abundance count dataYiming Shi, Huilin Li, Chan Wang, et al.Pancreas|November 6, 2019
Racial Differences in the Incidence and Survival of Patients With Neuroendocrine TumorsChan Shen, Dian Gu, Shouhao Zhou, et al.Cancer|January 4, 2019
The concomitant use of tyrosine kinase inhibitors and proton pump inhibitors: Prevalence, predictors, and impact on survival and discontinuation of therapy in older adults with cancerManvi Sharma, Holly M Holmes, Hemalkumar B Mehta, et al.Pageof 4